Brief: Qualigen Therapeutics On Feb 15, Entered Into License And Sublicense Agreement With Pan-Ras Holdings
Feb 22 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INC - ON FEB 15, 2024, ENTERED INTO
LICENSE AND SUBLICENSE AGREEMENT WITH PAN-RAS HOLDINGS
* QUALIGEN THERAPEUTICS - PAN-RAS HAS RIGHT TO TERMINATE
LICENSE &
SUBLICENSE AGREEMENT ON OR BEFORE MARCH 16
Source text for Eikon: ID:n0001493152-24-007562
Further company coverage: QLGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on FF EAI Robotics Ecosystem
See all newsBrief: Faraday Future Intelligent Electric Says FFR To Operate Robotics Business
Brief: Faraday Future Signs Deal to Transfer Robotics Business to FFR at $200 Mln Valuation
Faraday Future climbs after robotics unit deal, strategic upgrade into robotaxi operator
Brief: Aixcrypto Provides Context On Schedule 14C Filing
NASDAQ RESUMED AT 12:42 PM